Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
May-2019 Volume 17 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
May-2019 Volume 17 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

An integrative module analysis of DNA methylation landscape in aging

  • Authors:
    • Gang Li
    • Ke‑Yu Liu
    • Zhong‑Peng Qiu
  • View Affiliations / Copyright

    Affiliations: Department of Orthopedics, School of Medicine, Shihezi University, Shihezi, Xinjiang 832000, P.R. China
    Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 3411-3416
    |
    Published online on: March 1, 2019
       https://doi.org/10.3892/etm.2019.7334
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

To investigate the molecular mechanism of aging, the combination of module analysis and DNA methylation data was used to detect dynamically controlled modules for aging. Multiple differential expression networks (DENs) were constructed based on the microarray profiles across different aging groups (<70 years, 70‑80 years, and >80 years). Next, a module‑based approach was utilized to extract the common candidate modules across all age groups. We used Module Connectivity Dynamic Score (MCDS) to quantify the connectivity change of the common modules among the different age groups. Functional analyses were implemented for the genes in the common modules to further identify the significant biological processes. A total of two DENs were constructed. Overall 657 informative genes were screened out. When false discovery rate (FDR) was set as 0.05, we found that 148 modules were significant. Only 1 significant 2‑differential modules (DMs) (module 493) with dynamic changes was discovered. Significantly, the genes in the module 493 participated in 7 significant pathways, including pentose phosphate pathway, carbon metabolism, and citrate cycle (TCA cycle). In conclusion, pathway functions [pentose phosphate pathway, carbon metabolism, citrate cycle (TCA cycle), chromosomal instability, ateroid biosynthesis, PPAR signaling pathway, and immune response] may serve as potential therapeutic targets in aging.

Introduction

Aging is a natural as well as undeniable developmental process in human life, and ‘biological age’ is usually affected by many factors including environment, heredity, lifestyle, as well as any kind of disease (1). Developing reliable age-related measures is the main goal of gerontology (2). Biomarkers related to biological age have been identified in the research to detect the age of a person, and these signatures are significant for geriatric evaluation, which might be in favor of the adaptation of habits to assist healthy aging (3,4). Many aging biomarkers have been investigated, for example, telomere length, and mitochondrial DNA (5,6). Nevertheless, all of these signatures have a relatively low precision (7).

Methylated DNA is biologically and chemically more stable in relevance to mRNA. DNA methylation (DNAm) has been demonstrated to be an especially promising signature of aging (8–10). Bekaert et al (11) have predicted the person's age based on four age-associated DNAm biomarkers. Previous studies have demonstrated that the age-related epigenetic drift may be closely related to disease progression (12) and human evolution (13). Therefore, it is of great interest and importance to uncover the specific dynamics of DNAm landscape in aging.

As known, complicated diseases are believed to be induced by the perturbations of biological networks, other than single genes. Nevertheless, in a previous research, only two conditions were considered (that is to say, there is only one biological network) (14). Therefore, simultaneously measuring network dynamics in the progression of a disease is very important to understand the molecular mechanisms underlying the given disease. Of note, with the development of high throughput techniques, a great deal of protein interactions are collected, however, a number of interactions are yet not measured (15). This problem might be solved, to some extent, by utilizing modules or sub-networks within the complicated network (16). Hence, it is crucially important to detect significant modules in order to better understand the biological events related to aging.

In the present study, with the goal of detecting dynamically controlled modules related to aging, inference of multiple differential modules (iMDM) was utilized to analyze the DNA methylation data of aging at three age groups, in order to obtain the connectivity alterations of modules in the aging process. By utilizing iMDM to multiple sub-networks, candidate methylated genes were detected. We believe that our results can provide foundation for experimental verification in a future study, and expound the molecular mechanisms of aging.

Materials and methods

This module-based approach takes as input methylation data collected from control and disease cases, and is implemented based on the following steps: establishment of multiple differential expression networks (DENs) for each case; extraction of statistically significant multiple differential modules (DMs) in multiple DENs; quantification of the connectivity changes of the common multiple DMs; pathway and GO analyses for the genes in the common modules.

Microarray data

The microarray data of E-GEOD-64490 on aging were downloaded from the EMBL-EBI database (https://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-64490/), relying on the A-GEOD-13534 - Illumina Human-Methylation450 BeadChip (HumanMethylation450_15017482_v.1.1). In this study, gene microarray data of 48 samples were included. In the DNAm age, there were 14 samples with age <70 years, 29 samples of 70–80 years of age, and 5 samples of >80 years of age. After the probes were retrieved, we mapped the probes to the human gene symbols, and finally obtained 20,417 genes.

Protein-protein interaction network (PPIN) downloaded from STRING database

The human background PPIN covering 787,896 interactions and 16,730 genes was retrieved from STRING database (http://string-db.org/), and then only the common part of the microarray data and genes in the background PPIN were taken to construct the informative PPIN. Finally, 698,580 interactions were obtained.

Construction of DENs

For each age group, DEN was established based on the differential expression in the aging conditions. Firstly, on the basis of the absolute value of the Pearson's correlation coefficient (PCC) of any two genes, significant edges were selected to establish a binary co-expression network. Herein, we only selected the edges having PCC higher than the predefined value of 0.8 in order to construct the binary co-expression network. Secondly, we utilized one-side t-test to calculate the gene expressions in each age group. Using the P-value of differential gene expression in each age condition, we assigned the weight value to the interaction of the binary co-expression network. In view of multiple DENs, the same nodes were included but there were different edges; this was determined as Hk = (V, Ek) (1≤k≤M), where V is the node set of the co-expression network, Ek is represented by a 3-dimensional matrix A = (aijk)n × n × M, where aijk stands for the weight on the edge e(i,j), in network Hk, and M denotes the number of DEN.

Identifying candidate modules across multiple DENs

The unique and common modules across multiple DENs (that is to say, multiple candidate modules) were identified. Module algorithm (17) was developed to select gene modules with the same gene content, but different connectivity among multiple interaction networks. This module algorithm was applied to extract the candidate modules. The specific steps are described below.

Prioritization of informative genes

In order to obtain the informative genes, the genes in the multiple DENs were ranked using degree characteristics. Then, we obtained the sort order for each gene among all DENs based on the mean value of z-scores across all DENs. We selected and determined the top 10% genes as informative genes.

Module identification

Starting with each informative gene, module identification iteratively included genes whose addition led to the maximum reduction in the graph entropy-based function until no reduction was found.

Refining candidate modules

We removed the multiple candidate modules having node sizes <5. Jaccard index was used to merge the overlapping multiple candidate modules. In the present analysis, we set the threshold of the Jaccard index ≥0.5.

Statistical significance for multiple candidate modules

After obtaining the candidate modules, we implemented statistical significance for multiple candidate modules according to the null score distribution of candidate modules produced based on randomized networks. After that, Benjamini-Hochberg was utilized to adjust the P-values for multiple testing relying on false discovery rate (FDR) (18). FDR<0.05 was selected to be the significance threshold.

Connectivity dynamics of common multiple DMs and MCDS were used to further quantify the connectivity change of component modules

Analogously, we calculated the statistical significance of Module Connectivity Dynamic Score (MCDS) for a DM as that for multiple DMs. Concretely, we firstly computed the null distribution for MCDS scores according to the random multiple DMs. Then, we calculated the P-value for an MCDS on the basis of the null distribution. Benjamini-Hochberg was then used for correction. The DMs with greater connectivity were identified based on FDR<0.05.

Enrichment analysis for the genes in dynamic modules

To investigate the significant biological processes, DAVID was employed for pathway and GO annotation of genes in the dynamic modules. Expression Analysis Systematic Explorer (EASE) test was used to evaluate the significant pathways. Significant GO and pathway categories were determined according to FDR<0.05.

Results

Construction of multiple DENs

In addition to the age group <70 years, two conditions were also included, age group 70–80 years, and age group >80 years, multiple=2. Thus, a total of two DENs were constructed, and 2-DMs were identified. Significant genes and biological processes were then extracted after the significance of DMs and MCDS was evaluated. These significant genes and biological processes across the two conditions might provide novel insights on the molecular mechanism of aging progression.

After we mapped the microarray data to the background PPIN, an informative PPIN was extracted, which included 15,248 genes. To increase the network confidence, only interactions with scores ≥0.8 of the informative PPIN were selected in order to build DENs. Finally, we constructed two DENs, and each of them covered 87,702 edges, as well as 6,576 nodes. The DEN compositions are shown in Fig. 1.

Figure 1.

Compositions of DENs in comparison of the age groups (A) <70 years vs. 70–80 years, and (B) <70 years vs. >80 years. Green nodes represent the informative genes. DEN, differential expression network.

Identification of multiple candidate modules in two DENs and statistical significance of candidate modules

Using the z-score distribution of 6,576 nodes in the DENs, 657 informative genes were screened out. Afterwards, module search and refinement were conducted. Subsequently, a total of 162 candidate modules in the DENs of two aging conditions were identified. When FDR was set as 0.05, we found that there were 148 significant modules.

Common 2-DMs used to uncover dynamics during the development of aging

When FDR was set as 0.05, we found only module 493 observed in the DENs of aging group 70–80 years, and aging group >80 years was dynamic. This dynamic DM 493 including 187 nodes and 4,006 interactions is shown in Figs. 2 and 3. Among these 187 nodes, only one informative gene SLC10A3 appeared in this network. In the aging development, the connectivity of the interactions in this dynamic module was significantly changed, which further suggested that network rewired exerts key functions during the aging progression.

Figure 2.

One dynamics 2-DMs identified in the age groups <70 years and 70–80 years. Difference was calculated as ‘70–80 years age group - <70 years age group’. Green nodes represent the informative genes.

Figure 3.

One dynamics 2-DMs identified in the age groups <70 years and >80 years. Difference was calculated as ‘>80 years group - <70 years group’. Green nodes represent the informative genes.

Because the weight of edges in the DENs is a measurement of evaluating the differential expression between control and disease, the average edge weight acts as a way to assess the differential activity of the module. Figs. 4 and 5 show the weight distribution of the interactions in the dynamic 2-DMs for the aging groups 70–80 years and >80 years, respectively. As shown in Fig. 4, the majority of interactions in the network of the aging group 70–80 years are distributed in the weight distribution of 0.3–0.4, 0.4–0.5, and 0.5–0.6. However, the majority of interactions in the network of the aging group >80 years are distributed in the weight distribution of 0–0.1, and 0.1–0.2, as shown in Fig. 5.

Figure 4.

Weight distribution of the edges in the dynamic 2-DMs for the 70–80 years age group.

Figure 5.

Weight distribution of the edges in the dynamic 2-DMs for the >80 years age group.

Enrichment analysis

To investigate the biological processes, we implemented GO and pathway enrichment analysis for the genes in the dynamic module 493. Based on FDR<0.05, no GO terms were identified. However, overall 7 significant pathway terms were enriched in this dynamic module, including pentose phosphate pathway, carbon metabolism, citrate cycle (TCA cycle), chromosomal instability, ateroid biosynthesis, PPAR signaling pathway, and immune response.

Discussion

Aging is a major risk factor for chronic, metabolic and neurodegenerative disorders. Developing reliable age-related modules and functional categories is the main goal of gerontology, helpful to understand the potential mechanisms and provide signatures for assisting healthy aging. In our study, in order to explore the molecular events indicative of aging, the available DNA methylation data and DEN were integrated to investigate the altered modules and biological functions related to aging. Significantly, 1 dynamic dysregulated module (module 493) was extracted. GO enrichment results demonstrated that genes in module 493 were not involved in any category. Significantly, overall 7 significant pathway terms were enriched in the dynamic dysregulated module, including pentose phosphate pathway, carbon metabolism, citrate cycle (TCA cycle), chromosomal instability, ateroid biosynthesis, PPAR signaling pathway, and immune response.

Carbon metabolism that transforms carbon through pentose phosphate pathway, as well as TCA cycle to energy is essential for the physiology of brain, heart, liver, and kidneys (19). Significantly, mitochondria are responsible for ATP production, and progressive mitochondrial dysfunction, occurring with aging, leads to growing generation of reactive oxygen species (ROS), which in turn lead to further mitochondrial deterioration, as well as cellular damage (20). Furthermore, deletions and mutations of aged mitochondrial DNA have been reported to be related to aging (21). Of note, endurance training, as well as alternate-day-fasting has been suggested to enhance healthspan via avoiding mitochondrial degeneration (22). Thus, carbon metabolism, pentose phosphate pathway, and citrate cycle (TCA cycle) might exert significant functions in the progression of aging.

Chromosomal instability is one form of genomic instability, resulting from defects in chromosomal segregation, DNA damage, as well as telomere stability. Genetic evidence has demonstrated that the enhancement of the faithful chromosomal segregation can extend longevity in mammals (23). Telomere shortening is found in normal aging in mice and human (24). The premature aging of telomerase deficient mice can be reverted if telomerase is genetically reactivated in the aged mice (25). Accordingly, chromosomal instability is highly associated with aging progression.

Aging is implicated to be related to oxidative stress, which is regarded as the effector of the cascade of degenerative events (26). Oxidative stress is connected to the enhanced intracellular levels of ROS, and excessive production of ROS induces neuroinflammation, and neuronal death (27). Moderate increase of ROS has been demonstrated to serve as a molecular signal downstream effect which lure endogenous defense mechanisms, ending up with the increased stress resistance, as well as extended life span (28). Significantly, specific targets for a balanced ROS regulation are PPARs (29). In our study, the genes in the dynamic module participated in PPAR signaling pathway. Accordingly, PPAR signaling pathway might be highly related to the aging progression.

Immune system is an important component of the inflammatory process and is the natural response to infection. The recognition and elimination of senescent and hyperploid cells is an important role of the immune system (30). Inflammation plays important roles in the progression of obesity and diabetes, which are correlated with human aging (31). Overexpression of NF-κB pathway is observed in aging (32). Moreover, inhibiting NF-κB signaling pathway prevents age-related characteristics in mouse models of accelerated aging (33). Thus, we infer that aging might be modulated by NF-κB-driven inflammatory responses.

Taken together, this study has established interesting management options (dynamic DMs and the corresponding pathways) for the assessing the quality of life in the aging population. However, this study had several limitations. The number of samples was small which might cause a high false-positive rate of the findings. Moreover, no experimental confirmation was done in vivo or in vitro based on patient tissue or an animal model. Thus, suture studies with larger number of samples, using an animal model or patient tissues, are needed to confirm our preliminary findings obtained from bioinformatics analysis.

Acknowledgements

Not applicable.

Funding

No funding was received.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request.

Authors' contributions

GL was involved in the conception of the study, acquired the data and drafted the manuscript; KYL analyzed the data; ZPQ was involved in the conception of the study and revised the manuscript. All authors read and approved the final manuscript.

Ethics approval and consent to participate

Not applicable.

Patient consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

References

1 

Xu C, Qu H, Wang G, Xie B, Shi Y, Yang Y, Zhao Z, Hu L, Fang X, Yan J, et al: A novel strategy for forensic age prediction by DNA methylation and support vector regression model. Sci Rep. 5:177882015. View Article : Google Scholar : PubMed/NCBI

2 

Sanders JL, Boudreau RM, Penninx BW, Simonsick EM, Kritchevsky SB, Satterfield S, Harris TB, Bauer DC and Newman AB; Health ABC Study, : Association of a Modified Physiologic Index with mortality and incident disability: The Health, Aging, and Body Composition Study. J Gerontol A Biol Sci Med Sci. 67:1439–1446. 2012. View Article : Google Scholar : PubMed/NCBI

3 

Song Z, von Figura G, Liu Y, Kraus JM, Torrice C, Dillon P, Rudolph-Watabe M, Ju Z, Kestler HA, Sanoff H, et al: Lifestyle impacts on the aging-associated expression of biomarkers of DNA damage and telomere dysfunction in human blood. Aging Cell. 9:607–615. 2010. View Article : Google Scholar : PubMed/NCBI

4 

Zbieć-Piekarska R, Spólnicka M, Kupiec T, Parys-Proszek A, Makowska Ż, Pałeczka A, Kucharczyk K, Płoski R and Branicki W: Development of a forensically useful age prediction method based on DNA methylation analysis. Forensic Sci Int Genet. 17:173–179. 2015. View Article : Google Scholar : PubMed/NCBI

5 

Lin J, Epel E, Cheon J, Kroenke C, Sinclair E, Bigos M, Wolkowitz O, Mellon S and Blackburn E: Analyses and comparisons of telomerase activity and telomere length in human T and B cells: Insights for epidemiology of telomere maintenance. J Immunol Methods. 352:71–80. 2010. View Article : Google Scholar : PubMed/NCBI

6 

Cortopassi GA, Shibata D, Soong NW and Arnheim N: A pattern of accumulation of a somatic deletion of mitochondrial DNA in aging human tissues. Proc Natl Acad Sci USA. 89:7370–7374. 1992. View Article : Google Scholar : PubMed/NCBI

7 

Meissner C and Ritz-Timme S: Molecular pathology and age estimation. Forensic Sci Int. 203:34–43. 2010. View Article : Google Scholar : PubMed/NCBI

8 

Horvath S, Zhang Y, Langfelder P, Kahn RS, Boks MP, van Eijk K, van den Berg LH and Ophoff RA: Aging effects on DNA methylation modules in human brain and blood tissue. Genome Biol. 13:R972012. View Article : Google Scholar : PubMed/NCBI

9 

Day K, Waite LL, Thalacker-Mercer A, West A, Bamman MM, Brooks JD, Myers RM and Absher D: Differential DNA methylation with age displays both common and dynamic features across human tissues that are influenced by CpG landscape. Genome Biol. 14:R1022013. View Article : Google Scholar : PubMed/NCBI

10 

Numata S, Ye T, Hyde TM, Guitart-Navarro X, Tao R, Wininger M, Colantuoni C, Weinberger DR, Kleinman JE and Lipska BK: DNA methylation signatures in development and aging of the human prefrontal cortex. Am J Hum Genet. 90:260–272. 2012. View Article : Google Scholar : PubMed/NCBI

11 

Bekaert B, Kamalandua A, Zapico SC, Van de Voorde W and Decorte R: Improved age determination of blood and teeth samples using a selected set of DNA methylation markers. Epigenetics. 10:922–930. 2015. View Article : Google Scholar : PubMed/NCBI

12 

Teschendorff AE, Jones A, Fiegl H, Sargent A, Zhuang JJ, Kitchener HC and Widschwendter M: Epigenetic variability in cells of normal cytology is associated with the risk of future morphological transformation. Genome Med. 4:242012. View Article : Google Scholar : PubMed/NCBI

13 

West J, Widschwendter M and Teschendorff AE: Distinctive topology of age-associated epigenetic drift in the human interactome. Proc Natl Acad Sci USA. 110:14138–14143. 2013. View Article : Google Scholar : PubMed/NCBI

14 

Ma X, Gao L, Karamanlidis G, Gao P, Lee CF, Garcia-Menendez L, Tian R and Tan K: Revealing pathway dynamics in heart diseases by analyzing multiple differential networks. PLoS Comput Biol. 11:e10043322015. View Article : Google Scholar : PubMed/NCBI

15 

Nibbe RK, Chowdhury SA, Koyutürk M, Ewing R and Chance MR: Protein-protein interaction networks and subnetworks in the biology of disease. Wiley Interdiscip Rev Syst Biol Med. 3:357–367. 2011. View Article : Google Scholar : PubMed/NCBI

16 

Wu Y, Jing R, Jiang L, Jiang Y, Kuang Q, Ye L, Yang L, Li Y and Li M: Combination use of protein-protein interaction network topological features improves the predictive scores of deleterious non-synonymous single-nucleotide polymorphisms. Amino Acids. 46:2025–2035. 2014. View Article : Google Scholar : PubMed/NCBI

17 

Ma X, Gao L and Tan K: Modeling disease progression using dynamics of pathway connectivity. Bioinformatics. 30:2343–2350. 2014. View Article : Google Scholar : PubMed/NCBI

18 

Benjamini Y and Hochberg Y: Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc B. 57:289–300. 1995.

19 

Sauer U, Lasko DR, Fiaux J, Hochuli M, Glaser R, Szyperski T, Wüthrich K and Bailey JE: Metabolic flux ratio analysis of genetic and environmental modulations of Escherichia coli central carbon metabolism. J Bacteriol. 181:6679–6688. 1999.PubMed/NCBI

20 

Harman D: The free radical theory of aging: Effect of age on serum copper levels. J Gerontol. 20:151–153. 1965. View Article : Google Scholar : PubMed/NCBI

21 

Park CB and Larsson NG: Mitochondrial DNA mutations in disease and aging. J Cell Biol. 193:809–818. 2011. View Article : Google Scholar : PubMed/NCBI

22 

Safdar A, Bourgeois JM, Ogborn DI, Little JP, Hettinga BP, Akhtar M, Thompson JE, Melov S, Mocellin NJ, Kujoth GC, et al: Endurance exercise rescues progeroid aging and induces systemic mitochondrial rejuvenation in mtDNA mutator mice. Proc Natl Acad Sci USA. 108:4135–4140. 2011. View Article : Google Scholar : PubMed/NCBI

23 

Baker DJ, Dawlaty MM, Wijshake T, Jeganathan KB, Malureanu L, van Ree JH, Crespo-Diaz R, Reyes S, Seaburg L, Shapiro V, et al: Increased expression of BubR1 protects against aneuploidy and cancer and extends healthy lifespan. Nat Cell Biol. 15:96–102. 2013. View Article : Google Scholar : PubMed/NCBI

24 

Blasco MA: Telomere length, stem cells and aging. Nat Chem Biol. 3:640–649. 2007. View Article : Google Scholar : PubMed/NCBI

25 

Jaskelioff M, Muller FL, Paik JH, Thomas E, Jiang S, Adams AC, Sahin E, Kost-Alimova M, Protopopov A, Cadiñanos J, et al: Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice. Nature. 469:102–106. 2011. View Article : Google Scholar : PubMed/NCBI

26 

Finkel T and Holbrook NJ: Oxidants, oxidative stress and the biology of ageing. Nature. 408:239–247. 2000. View Article : Google Scholar : PubMed/NCBI

27 

Mattson MP: Calcium and neurodegeneration. Aging Cell. 6:337–350. 2007. View Article : Google Scholar : PubMed/NCBI

28 

Ristow M and Schmeisser S: Extending life span by increasing oxidative stress. Free Radic Biol Med. 51:327–336. 2011. View Article : Google Scholar : PubMed/NCBI

29 

Zolezzi JM, Silva-Alvarez C, Ordenes D, Godoy JA, Carvajal FJ, Santos MJ and Inestrosa NC: Peroxisome proliferator-activated receptor (PPAR) γ and PPARα agonists modulate mitochondrial fusion-fission dynamics: Relevance to reactive oxygen species (ROS)-related neurodegenerative disorders? PLoS One. 8:e640192013. View Article : Google Scholar : PubMed/NCBI

30 

Senovilla L, Vitale I, Martins I, Tailler M, Pailleret C, Michaud M, Galluzzi L, Adjemian S, Kepp O, Niso-Santano M, et al: An immunosurveillance mechanism controls cancer cell ploidy. Science. 337:1678–1684. 2012. View Article : Google Scholar : PubMed/NCBI

31 

Barzilai N, Huffman DM, Muzumdar RH and Bartke A: The critical role of metabolic pathways in aging. Diabetes. 61:1315–1322. 2012. View Article : Google Scholar : PubMed/NCBI

32 

Adler AS, Sinha S, Kawahara TLA, Zhang JY, Segal E and Chang HY: Motif module map reveals enforcement of aging by continual NF-kappaB activity. Genes Dev. 21:3244–3257. 2007. View Article : Google Scholar : PubMed/NCBI

33 

Tilstra JS, Robinson AR, Wang J, Gregg SQ, Clauson CL, Reay DP, Nasto LA, St Croix CM, Usas A, Vo N, et al: NF-κB inhibition delays DNA damage-induced senescence and aging in mice. J Clin Invest. 122:2601–2612. 2012. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Li G, Liu KY and Qiu ZP: An integrative module analysis of DNA methylation landscape in aging. Exp Ther Med 17: 3411-3416, 2019.
APA
Li, G., Liu, K., & Qiu, Z. (2019). An integrative module analysis of DNA methylation landscape in aging. Experimental and Therapeutic Medicine, 17, 3411-3416. https://doi.org/10.3892/etm.2019.7334
MLA
Li, G., Liu, K., Qiu, Z."An integrative module analysis of DNA methylation landscape in aging". Experimental and Therapeutic Medicine 17.5 (2019): 3411-3416.
Chicago
Li, G., Liu, K., Qiu, Z."An integrative module analysis of DNA methylation landscape in aging". Experimental and Therapeutic Medicine 17, no. 5 (2019): 3411-3416. https://doi.org/10.3892/etm.2019.7334
Copy and paste a formatted citation
x
Spandidos Publications style
Li G, Liu KY and Qiu ZP: An integrative module analysis of DNA methylation landscape in aging. Exp Ther Med 17: 3411-3416, 2019.
APA
Li, G., Liu, K., & Qiu, Z. (2019). An integrative module analysis of DNA methylation landscape in aging. Experimental and Therapeutic Medicine, 17, 3411-3416. https://doi.org/10.3892/etm.2019.7334
MLA
Li, G., Liu, K., Qiu, Z."An integrative module analysis of DNA methylation landscape in aging". Experimental and Therapeutic Medicine 17.5 (2019): 3411-3416.
Chicago
Li, G., Liu, K., Qiu, Z."An integrative module analysis of DNA methylation landscape in aging". Experimental and Therapeutic Medicine 17, no. 5 (2019): 3411-3416. https://doi.org/10.3892/etm.2019.7334
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team